NEXUS BIOPHARMA INC Proceeds from Notes Payable
NEXUS BIOPHARMA INC reported Proceeds from Notes Payable of $292.50 thousand for the 12-month period ending 2017-02-28, per its 10-K filed 2017-07-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2017-10-27
- NEXUS BIOPHARMA INC proceeds from notes payable for the quarter ending 2017-02-28 was $0.00.
- NEXUS BIOPHARMA INC proceeds from notes payable for the quarter ending 2016-11-30 was $0.00.
- NEXUS BIOPHARMA INC proceeds from notes payable for the quarter ending 2016-08-31 was $0.00.
- NEXUS BIOPHARMA INC proceeds from notes payable for the quarter ending 2016-05-31 was $292.50K.
- NEXUS BIOPHARMA INC proceeds from notes payable for fiscal 2017 was $292.50K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2017-02-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-05 | $0.00 derived: sum of 2 quarters · filed 2017-07-05 | $0.00 derived: sum of 3 quarters · filed 2017-07-05 | $292.50K 10-K · filed 2017-07-05 |
| 2016-11-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-10 | $0.00 derived: sum of 2 quarters · filed 2017-04-10 | $292.50K 10-Q · filed 2017-04-10 | |
| 2016-08-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-10-24 | $292.50K 10-Q · filed 2016-10-24 | ||
| 2016-05-31 | $292.50K 10-Q · filed 2017-10-27 |